Cornell chemistry researchers have designed a light-powered, reusable catalyst that’s pre-charged by electricity and capable of driving challenging reactions, with applications including drug development and environmental clean-up.
A new $5 million initiative, funded by the Astera Institute with experimental work conducted at the Cornell High Energy Synchrotron Source, aims to make diffuse scattering accessible to the public and the broader scientific community.
Antonio Fernandez-Ruiz, assistant professor and Nancy and Peter Meinig Family Investigator in the Life Sciences in the Department of Neurobiology and Behavior in the College of Arts and Sciences, has been awarded a biomedical sciences grant from the Pew Charitable Trusts.
“How to Have Willpower: An Ancient Guide to Not Giving In,” edited and translated by professor Michael Fontaine, brings together a pair of works by Plutarch and Prudentius that show how people can overcome pressures that encourage them to act against their own best interests.
Researchers developed machine-learning models that can sift through cell-free RNA and identify key biomarkers for chronic fatigue syndrome, a debilitating disease that is difficult to confirm in patients because its symptoms can be easily confused with those of other illnesses.
Bittner-Singer Orchards, a 400-acre farm in Niagara County along the shores of Lake Ontario, looks like your average orchard but is also a site of cutting-edge Cornell research.
Cornell researchers have developed an implant system that can treat Type 1 diabetes by supplying extra oxygen to densely packed insulin-secreting cells, without the need for immunosuppression.
